Correlation Between Korean Drug and Genic
Can any of the company-specific risk be diversified away by investing in both Korean Drug and Genic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korean Drug and Genic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korean Drug Co and Genic Co, you can compare the effects of market volatilities on Korean Drug and Genic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korean Drug with a short position of Genic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korean Drug and Genic.
Diversification Opportunities for Korean Drug and Genic
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Korean and Genic is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Korean Drug Co and Genic Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genic and Korean Drug is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korean Drug Co are associated (or correlated) with Genic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genic has no effect on the direction of Korean Drug i.e., Korean Drug and Genic go up and down completely randomly.
Pair Corralation between Korean Drug and Genic
Assuming the 90 days trading horizon Korean Drug Co is expected to under-perform the Genic. But the stock apears to be less risky and, when comparing its historical volatility, Korean Drug Co is 2.26 times less risky than Genic. The stock trades about -0.04 of its potential returns per unit of risk. The Genic Co is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 509,000 in Genic Co on October 13, 2024 and sell it today you would earn a total of 2,206,000 from holding Genic Co or generate 433.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.79% |
| Values | Daily Returns |
Korean Drug Co vs. Genic Co
Performance |
| Timeline |
| Korean Drug |
| Genic |
Korean Drug and Genic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Korean Drug and Genic
The main advantage of trading using opposite Korean Drug and Genic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korean Drug position performs unexpectedly, Genic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genic will offset losses from the drop in Genic's long position.| Korean Drug vs. Dongbang Transport Logistics | Korean Drug vs. Samyang Foods Co | Korean Drug vs. BIT Computer Co | Korean Drug vs. Korean Reinsurance Co |
| Genic vs. Nh Investment And | Genic vs. DB Financial Investment | Genic vs. Korean Drug Co | Genic vs. NH Investment Securities |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world |